Joshua Zeidner, Omer Jamy, Bradley Christensen, Sharif Khan, Dragan Cicic, Tapan Kadia. "Phase 2 study of SLS009 in combination with azacitidine and venetoclax for relapsed/refractory AML with MDS-related changes (AML-MR) after prior venetoclax treatment." Blood, 2025. doi:10.1182/blood-2025-3423